Revenue
2015
2016
2017
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2,183 | — | — | — | — | — | — | — | $78,260 | $0 | $0 |
| Research & development | — | — | — | — | — | — | — | $90,060 | $151,981 | $221,688 | $37,014 |
| Operating expenses | $3.3M | $2.5M | $1.6M | $3.3M | $9.1M | $3.9M | $411,019 | $761,936 | $796,585 | $1.1M | $491,108 |
| Operating income | −$3.3M | −$2.5M | −$1.6M | −$3.3M | −$9.1M | −$3.9M | $411,019 | −$761,936 | −$796,585 | −$1.1M | −$491,108 |
| EBITDAderived | — | −$1.8M | — | — | −$8.7M | — | — | — | — | — | — |
| Net income | −$2.5M | −$2.1M | −$2.0M | −$4.2M | −$10.2M | −$3.5M | −$3.6M | −$5.6M | −$4.1M | −$1.5M | −$600,835 |
| Basic EPSper diluted share | -$0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.07 | -$0.11 | -$0.18 | -$7.17 | -$0.06 | -$0.05 | -$0.03 |
| Diluted EPSper diluted share | -$0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.07 | -$0.11 | -$0.18 | -$7.17 | -$0.06 | -$0.05 | -$0.03 |